Traditionally, the microbiologic diagnosis of RSV has been based on moderate to complex techniques performed in a laboratory (cell culture, nucleic acid amplification and immunofluorescence assays ...

GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing a rare neurological disorder, the U.S. Food Drug Administration said on ...

The other vaccine, mResvia, is an mRNA-based vaccine that sends signals to your cells to produce the same protein F that causes the immune reaction that fights against RSV. These vaccines are ...

The novel treatment consists of a single shot which is made of special proteins called antibodies that bind to the site at ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.